# Ovid Therapeutics Inc. (OVID) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$42M |
| 2024 | -$62M |
| 2023 | -$59M |
| 2022 | -$56M |
| 2021 | $124M |
| 2020 | -$81M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$18M |
| 2025-09-30 | -$13M |
| 2025-06-30 | -$5M |
| 2025-03-31 | -$13M |
| 2024-09-30 | -$13M |
| 2024-06-30 | -$21M |
| 2024-03-31 | -$17M |
| 2023-09-30 | -$12M |
| 2023-06-30 | -$14M |
| 2023-03-31 | -$15M |
| 2022-09-30 | -$13M |
| 2022-06-30 | -$14M |
| 2022-03-31 | -$16M |
| 2021-09-30 | -$12M |
| 2021-06-30 | -$14M |
| 2021-03-31 | $177M |
| 2020-09-30 | -$16M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/OVID/operating-income)